Novo Nordisk's first phase III data for weekly insulin to be released in few months
![Photo: Novo Nordisk Pharmatech/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13792737.ece/ALTERNATES/schema-16_9/doc7jynk96wiz518hxbe96r.jpg)
Novo Nordisk is expecting to conclude its phase III program, dubbed Onwards, with its once-weekly insulin Icodec in 2022.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Wegovy update on Novo Nordisk's capital markets day agenda
For subscribers